{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "Urine culture and urine cytology were negative.",
        "clinical_data": {
          "labs": [
            {
              "test": "UMLS:C0042129",
              "value": "negative",
              "unit": null,
              "flag": "normal"
            },
            {
              "test": "UMLS:C0347014",
              "value": "negative",
              "unit": null,
              "flag": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Cystoscopy showed diffuse mucosal redness and bleeding.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Cystoscopy",
              "approach": "endoscopic",
              "location": "bladder",
              "finding": "diffuse mucosal redness and bleeding"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient was started on methylprednisolone 60 mg/day (1 mg/kg). Symptoms and cystoscopic inflammatory findings improved immediately.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0025524",
              "dosage": "60 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Methylprednisolone was reduced to 20 mg/day and the patient was discharged home while continuing methylprednisolone 20 mg/day.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0025727",
              "dosage": "20 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "One month after discharge, the patient experienced a recurrence of glans penile pain, micturition pain, and pyuria. Cystoscopy revealed inflammatory findings in the bladder mucosa.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Recurrence of glans penile pain, micturition pain, and pyuria one month after discharge.",
              "duration": "1 month",
              "onset": "1 month after discharge",
              "progression": "unknown",
              "associated_symptoms": [
                "Pain",
                "Pyuria"
              ]
            }
          ],
          "diagnoses": [
            {
              "code": "Inflammatory findings",
              "label": "Inflammatory findings in the bladder mucosa",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Urine culture was negative again.",
        "clinical_data": {
          "labs": [
            {
              "test": "UMLS:C0042134",
              "value": "negative",
              "unit": null,
              "flag": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "One month after discharge, the dose of methylprednisolone was gradually increased, but symptoms markedly enhanced. The dose of methylprednisolone was increased to 60 mg/day, 3 weeks after the recurrence of symptoms.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0025309",
              "dosage": "60 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": "recurrence of symptoms"
            }
          ],
          "HPI": [
            {
              "summary": "Symptoms markedly enhanced one month after discharge, despite gradual increase in methylprednisolone dose. Symptoms recurred 3 weeks prior to methylprednisolone dose increase.",
              "duration": "1 month",
              "onset": null,
              "progression": "fluctuating",
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "After increasing the dose of methylprednisolone to 60\u2009mg/day, the symptoms and pyuria improved. It was difficult to reduce the dose of methylprednisolone below 40\u2009mg/day.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0025307",
              "dosage": "60 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "indication": null
            },
            {
              "drug": "C0025307",
              "dosage": "40 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "indication": null
            }
          ],
          "labs": [
            {
              "test": "Pyuria",
              "value": "positive",
              "flag": "abnormal"
            }
          ],
          "HPI": [
            {
              "summary": "Symptoms improved after increasing methylprednisolone dose.",
              "alleviating_factors": [
                "C0025307"
              ]
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "Infliximab (5\u2009mg/kg) administered in conjunction with methylprednisolone. Symptoms of steroid\u2010resistant cystitis were relieved early by concomitant use of infliximab.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0678157",
              "dosage": "5 mg/kg",
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0010623"
            },
            {
              "drug": "C0025307",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0010623"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Progression from negative urine culture and cytology to cystoscopic findings."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Initiation of methylprednisolone treatment following cystoscopy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025524"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Reduction of methylprednisolone dosage prior to discharge.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025727"
          ],
          "change_type": "deescalation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Recurrence of symptoms one month after discharge.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0239288",
            "C0025797",
            "C0036384"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Urine culture remains negative despite symptom recurrence."
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Escalation of methylprednisolone dosage due to symptom recurrence.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025309"
          ],
          "change_type": "escalation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Improvement of symptoms and pyuria after increasing methylprednisolone dose.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025307"
          ],
          "change_type": "escalation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Administration of infliximab in conjunction with methylprednisolone for steroid-resistant cystitis.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0678157",
            "C0025307"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    }
  ]
}